About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: January 14, 2008
Begin Communications Earlier in the Drug Review Process
One of the many lessons available from the track record of the FDA last year involves communications and preparation for advisory committee and FDA approvals. There increasing numbers of approvable letters than there were declines in approvals last year. There … Continue reading
Posted in Advisory Committee Prepapartion
Comments Off on Begin Communications Earlier in the Drug Review Process